CD8+ T-cells are also noted to be inhibited by high concentrations of 2-HG, and in vitro models have indicated potential for immune evasion by tumors with mutated IDH; this has not yet been demonstrated in AML [76,77,78]. This evidence concerns the gene IDH1 and acute myeloid leukemia.